RedHill Biopharma (RDHL) Interest Coverage Ratio (2016 - 2023)
Historic Interest Coverage Ratio for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to 27.91.
- RedHill Biopharma's Interest Coverage Ratio rose 118405.85% to 27.91 in Q2 2023 from the same period last year, while for Jun 2023 it was 1.2, marking a year-over-year increase of 8069.87%. This contributed to the annual value of 7107490.27 for FY2024, which is 54043268443.75% down from last year.
- Latest data reveals that RedHill Biopharma reported Interest Coverage Ratio of 27.91 as of Q2 2023, which was up 118405.85% from 69.07 recorded in Q1 2023.
- In the past 5 years, RedHill Biopharma's Interest Coverage Ratio registered a high of 167.3 during Q2 2019, and its lowest value of 69.07 during Q1 2023.
- Moreover, its 5-year median value for Interest Coverage Ratio was 4.29 (2020), whereas its average is 15.0.
- As far as peak fluctuations go, RedHill Biopharma's Interest Coverage Ratio soared by 290564.47% in 2019, and later tumbled by 172372.26% in 2023.
- Quarter analysis of 5 years shows RedHill Biopharma's Interest Coverage Ratio stood at 62.91 in 2019, then plummeted by 93.12% to 4.33 in 2020, then tumbled by 987.5% to 38.41 in 2021, then increased by 20.52% to 30.53 in 2022, then surged by 191.42% to 27.91 in 2023.
- Its Interest Coverage Ratio was 27.91 in Q2 2023, compared to 69.07 in Q1 2023 and 30.53 in Q4 2022.